2.04 USD
↗ 0.25 (13.97%)AT CLOSE (11:59 AM EDT)
ALX Oncology Holdings Inc. Common Stock
ALXONASDAQ • USD
2.02
↘ 0.03 (1.23%)
POST MARKET (AS OF 07:31 PM EDT)
Post Market
AS OF 07:31 PM EDT
2.02
↘ 0.03 (1.23%)
Market: CLOSED
ALX Oncology Holdings Inc. Common Stock (ALXO) trades at $2.04 per share. ALXO shows a split signal: technical indicators suggest "Strong Buy" while underlying fundamentals indicate "Sell". This is driven by a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 0/9, negative Return on Equity and a bullish Golden Cross on the moving averages. Valuation metrics suggest ALXO is trading at a discount to its peers, earning an "Attractively Valued" rating.
Technical & fundamental data as of Jun 26, 2026.
Open?$1.79
High?$2.13
Low?$1.77
Prev. Close?$1.79
Volume?14.5M
Avg. Volume?1.7M
VWAP?$1.95
Rel. Volume?8.48x
Bid / Ask
Bid?$1.74 × 100
Ask?$2.49 × 100
Spread?$0.75
Midpoint?$2.12
Valuation & Ratios
Market Cap?274.5M
Shares Out?134.6M
Float?92.5M
Float %?68.8%
P/E Ratio?N/A
P/B Ratio?1.81
EPS?-$0.66
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
ALX Oncology Holdings Inc is a clinical-stage immuno-oncology company focused on helping patients fight cancer by developing a pipeline of product candidates based on expertise in protein engineering and oncology led by the CD47 blocker, evorpacept, currently in phase 1 and 2 clinical trials. Cancer cells leverage CD47, a cell surface protein, as a don't eat me signal to evade detection by the immune system. It is developing a next-generation checkpoint inhibitor designed to have a high affinity for CD47 and to avoid the limitations caused by hematologic toxicities inherent in other CD47 blocking approaches.
Employees
43
Market Cap
240.9M
Industry
PHARMACEUTICAL PREPARATIONS
Website
Listed
2020-07-17
Address
323 ALLERTON AVENUE
SOUTH SAN FRANCISCO, CA 94080
Phone: 650-466-7125
SOUTH SAN FRANCISCO, CA 94080
Phone: 650-466-7125
Technical OutlookStrong Buy
Strong SellNeutralStrong Buy
Long-Term (Tide)?▲ Bullish(+2/3)
Medium-Term (Wave)?▲ Bullish(+2/3)
Short-Term (Ripple)?▲ Bullish(+2/3)
MA Alignment?Mixed
Full Technical Analysis →Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?3
Z-Score?1
Momentum?65
Short Sent.?54
Piotroski F-Score?0/9Weak
Altman Z-Score?-0.55Distress
Confidence?51%Low
Short InterestLow
Short % of Float?2.80%Low
Short Interest?2.6M
Days to Cover?2.6
Free Float92.5M
Avg Daily Volume980.9K
Settlement Date2026-06-15
Financial Health
Current Ratio?7.21Strong
Quick Ratio?7.21Strong
Cash Ratio?1.60Strong
Debt/Equity?0.06Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score100/100
P/E?N/A▾
P/B?1.81CHEAP▾
Peers100
S&P80
P/S?N/A▾
P/FCF?N/A▾
EV/EBITDA?-2.9CHEAP▾
S&P97
EV/Sales?N/A▾
Returns & Efficiency
ROE?-58.7%WEAK▾
S&P3
ROA?-49.8%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$-78329000
Enterprise Value?$250.7M
Fundamentals ratios updated end of day